Aveanna Healthcare (NASDAQ:AVAH) CAO Sells $93,901.70 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,962 shares of the firm’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $93,901.70. Following the completion of the transaction, the chief accounting officer directly owned 251,676 shares in the company, valued at approximately $1,975,656.60. This represents a 4.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Deborah Stewart also recently made the following trade(s):

• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total transaction of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total transaction of $95,128.44.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $8.08 on Monday. The stock has a market cap of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32. The firm has a fifty day moving average price of $8.92 and a 200-day moving average price of $7.52. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The company had revenue of $450.53 million for the quarter. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of AVAH. Banque Transatlantique SA purchased a new position in shares of Aveanna Healthcare in the first quarter valued at $25,000. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the second quarter valued at $43,000. Diversified Trust Co bought a new position in Aveanna Healthcare during the second quarter valued at $57,000. Jump Financial LLC purchased a new position in shares of Aveanna Healthcare in the 1st quarter worth $59,000. Finally, MQS Management LLC bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth about $59,000. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare News Roundup

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Analysts Set New Price Targets

Several brokerages recently issued reports on AVAH. William Blair initiated coverage on Aveanna Healthcare in a research note on Monday, December 8th. They set an “outperform” rating on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. JPMorgan Chase & Co. raised shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, BMO Capital Markets assumed coverage on shares of Aveanna Healthcare in a report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price target on the stock. Five investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.69.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.